listingmili.blogg.se

Moneycontrol sun pharma
Moneycontrol sun pharma





moneycontrol sun pharma
  1. MONEYCONTROL SUN PHARMA FULL
  2. MONEYCONTROL SUN PHARMA TORRENT

The profit margin of 33. The PE is very low and attractive compared to its peers.

moneycontrol sun pharma

MONEYCONTROL SUN PHARMA TORRENT

EquityPandit predicts range for the Weekly as 1112 upside and 954 on downside. This analysis is based on the secondary data from the Annual reports, moneycontrol. Sun pharma PE 59, Cipla 35, Torrent 70, whereas Divis PE is just 29.2. Stock is trading above 200 days exponential moving average, suggests long term trend is bullish. If stock breaches minor support on the downside and closes below it we may see fresh break down and stock can drag towards Major Support on lower side 954 and If stock breaches minor resistance on the upside and closes above it we may see fresh breakout and stock can head towards Major Resistances Level 1112 Technically on the daily charts EquityPandit’s Analyst see: Minor support on the downside lies at 996 levels, Minor resistance on the upside is capped around 1075 levels. Sun Pharma Outlook for the Week (– Nov 11, 2022) BSE: 524715 NSE: SUNPHARMA ISIN: INE044A01036 SECTOR: PHARMA Stock closed the Weekly on Positive note gaining 5.04 Sun Pharma Share Price: 1093.90 Weekly High: 1070.95 Weekly Low: 991.20 Weekly Range: 49.

moneycontrol sun pharma

The Nifty Pharma index closed 1.43 per cent down at 13230.0. Weekly Support & Resistance For Sun Pharma: RESISTANCE 2 Sun Pharma Advanced Research Company shares rallied 6 percent to Rs 260.75, the highest closing level since May 2 this year and formed long bullish candle on the daily charts with above average. On the other hand, Divis Laboratories (down 8.86 per cent), Alembic Pharmaceuticals (down 4.34 per cent), Cipla (down 1.33 per cent), Granules India (down 1.19 per cent) and Sun Pharmaceutical Industries (down 1.11 per cent) finished as the top losers of the day. Stock closed the Weekly on Positive note gaining 5.04%

MONEYCONTROL SUN PHARMA FULL

Check SUNPHARMA Full Analysis At Unicorn Signals SUNPHARMA Weekly Outlook and Analysis:įor the Week: (– Nov 11, 2022) Sun Pharma Outlook for the Week (– Nov 11, 2022)Ĭheck SUNPHARMA Full Analysis At Unicorn SignalsīSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA







Moneycontrol sun pharma